Cargando…
Intravenous Colistin in the treatment of multidrug-resistant Acinetobacter in neonates
BACKGROUND: Neonatal sepsis caused by multidrug-resistant gram-negative bacteria has been reported in different parts of the world. It is a major threat to neonatal care, carrying a high rate of morbidity and mortality. While Colistin is the treatment of choice, few studies have reported its use in...
Autores principales: | Al-lawama, Manar, Aljbour, Haytham, Tanash, Asma, Badran, Eman |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2016
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4751699/ https://www.ncbi.nlm.nih.gov/pubmed/26868136 http://dx.doi.org/10.1186/s12941-016-0126-4 |
Ejemplares similares
-
Intravenous Immunoglobulins as Adjunct Treatment to Phototherapy in Isoimmune Hemolytic Disease of the Newborn: A Retrospective Case-Control Study
por: Al-lawama, Manar, et al.
Publicado: (2019) -
Combination Treatment with Intravenous Tigecycline and Intraventricular and Intravenous Colistin in Postoperative Ventriculitis Caused by Multidrug-resistant Acinetobacter baumannii
por: Mizrahi, Cezar J, et al.
Publicado: (2019) -
Adoption of the American Academy of Pediatrics’ neonatal hyperbilirubinemia guidelines and its effect on blood exchange transfusion rate in a tertiary care center in Amman, Jordan
por: Al-Lawama, Manar, et al.
Publicado: (2018) -
Prolonged Rupture of Membranes, Neonatal Outcomes and Management Guidelines
por: Al-lawama, Manar, et al.
Publicado: (2019) -
Multidrug-resistant Acinetobacter meningitis treated by intrathecal colistin
por: Singh, Rajesh K., et al.
Publicado: (2017)